CD133+CD44+ population efficiently enriches colon cancer initiating cells - PubMed (original) (raw)
. 2008 Oct;15(10):2927-33.
doi: 10.1245/s10434-008-0074-0. Epub 2008 Jul 29.
Affiliations
- PMID: 18663533
- DOI: 10.1245/s10434-008-0074-0
CD133+CD44+ population efficiently enriches colon cancer initiating cells
Naotsugu Haraguchi et al. Ann Surg Oncol. 2008 Oct.
Abstract
Background: Previous reports have demonstrated that CD133(+) cells or CD44(+) cells might be cancer initiating cells (CIC) of colon cancer. However, the association between the two cell types is unclear. In this study, we evaluated the tumorigenicity of each population of human colon cancer divided by CD133 and CD44 using non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice.
Methods: Using the colon cancer cell lines HT29 and Caco2 we evaluated the change of expression status of CD133 or CD44 by a treatment with sodium butyrate (NaBT) that can induce cellular differentiation. Next, we prepared ten clinical samples of colon cancer and analyzed the expression and tumorigenicity of CD133 and CD44.
Results: With NaBT treatment, CD44 expression was greatly downregulated in both HT29 and Caco2 (HT29: nontreatment versus treatment; 77.8% versus 0.6%, Caco2: 14.0% versus 0.4%, respectively), more than CD133 expression (HT29: nontreatment versus treatment; 90.1% versus 67.7%, Caco2: 98.9% versus 76.3%, respectively). In clinical samples, the percentages of CD133(+) cells and CD44(+) cells varied from 0.3% to 82.0% (mean 35.5%), and from 11.5% to 58.4% (mean 30.0%), respectively. Subcutaneous injection of CD133(+) or CD44(+) cells made a tumor in all mice (3/3 and 4/4, respectively). The combined analysis of CD133 and CD44 revealed that only the CD133(+)CD44(+) population had the ability to produce a tumor (3/3).
Conclusion: The findings demonstrate that, at present, the CD133(+)CD44(+ ) population may be the best to identify tumor initiating cells of human colon cancer.
Similar articles
- CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
Haraguchi N, Ishii H, Mimori K, Ohta K, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M. Haraguchi N, et al. Int J Oncol. 2013 Aug;43(2):425-30. doi: 10.3892/ijo.2013.1955. Epub 2013 May 24. Int J Oncol. 2013. PMID: 23708747 - CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
Rocco A, Liguori E, Pirozzi G, Tirino V, Compare D, Franco R, Tatangelo F, Palaia R, D'Armiento FP, Pollastrone G, Affuso A, Bottazzi EC, Masone S, Persico G, Nardone G. Rocco A, et al. J Cell Physiol. 2012 Jun;227(6):2686-93. doi: 10.1002/jcp.23013. J Cell Physiol. 2012. PMID: 21898409 - Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
Chen KL, Pan F, Jiang H, Chen JF, Pei L, Xie FW, Liang HJ. Chen KL, et al. Clin Exp Metastasis. 2011 Dec;28(8):751-63. doi: 10.1007/s10585-011-9407-7. Epub 2011 Jul 13. Clin Exp Metastasis. 2011. PMID: 21750907 - Cancer initiating cells or cancer stem cells in the gastrointestinal tract and liver.
Zou GM. Zou GM. J Cell Physiol. 2008 Dec;217(3):598-604. doi: 10.1002/jcp.21541. J Cell Physiol. 2008. PMID: 18651561 Review. - The most reliable surface marker for the identification of colorectal cancer stem-like cells: A systematic review and meta-analysis.
Abbasian M, Mousavi E, Arab-Bafrani Z, Sahebkar A. Abbasian M, et al. J Cell Physiol. 2019 Jun;234(6):8192-8202. doi: 10.1002/jcp.27619. Epub 2018 Oct 14. J Cell Physiol. 2019. PMID: 30317669 Review.
Cited by
- Ascl2 knockdown results in tumor growth arrest by miRNA-302b-related inhibition of colon cancer progenitor cells.
Zhu R, Yang Y, Tian Y, Bai J, Zhang X, Li X, Peng Z, He Y, Chen L, Pan Q, Fang D, Chen W, Qian C, Bian X, Wang R. Zhu R, et al. PLoS One. 2012;7(2):e32170. doi: 10.1371/journal.pone.0032170. Epub 2012 Feb 23. PLoS One. 2012. PMID: 22384170 Free PMC article. - Response to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620.
Hsu CS, Tung CY, Yang CY, Lin CH. Hsu CS, et al. PLoS One. 2013;8(4):e61133. doi: 10.1371/journal.pone.0061133. Epub 2013 Apr 5. PLoS One. 2013. PMID: 23577199 Free PMC article. - Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma.
Tovuu LO, Imura S, Utsunomiya T, Morine Y, Ikemoto T, Arakawa Y, Mori H, Hanaoka J, Kanamoto M, Sugimoto K, Iwahashi S, Saito Y, Yamada S, Asanoma M, Miyake H, Shimada M. Tovuu LO, et al. Int J Clin Oncol. 2013 Aug;18(4):651-6. doi: 10.1007/s10147-012-0432-6. Epub 2012 Jun 16. Int J Clin Oncol. 2013. PMID: 22706704 - CD133(+) single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potential.
Li G, Liu C, Yuan J, Xiao X, Tang N, Hao J, Wang H, Bian X, Deng Y, Ding Y. Li G, et al. Clin Exp Metastasis. 2010 Oct;27(7):517-27. doi: 10.1007/s10585-010-9341-0. Epub 2010 Jul 9. Clin Exp Metastasis. 2010. PMID: 20617370 - Evidence for the osteosarcoma stem cell.
Gibbs CP Jr, Levings PP, Ghivizzani SC. Gibbs CP Jr, et al. Curr Orthop Pract. 2011 Jul;22(4):322-326. doi: 10.1097/BCO.0b013e318221aee8. Curr Orthop Pract. 2011. PMID: 21755019 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous